Logo image of CLSK

CLEANSPARK INC (CLSK) Stock Fundamental Analysis

NASDAQ:CLSK - US18452B2097 - Common Stock

9.55 USD
-0.03 (-0.31%)
Last: 8/28/2025, 8:01:14 PM
9.59 USD
+0.04 (+0.42%)
After Hours: 8/28/2025, 8:01:14 PM
Fundamental Rating

5

Taking everything into account, CLSK scores 5 out of 10 in our fundamental rating. CLSK was compared to 282 industry peers in the Software industry. CLSK scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. CLSK is not priced too expensively while it is growing strongly. Keep and eye on this one!


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year CLSK was profitable.
In the past year CLSK has reported a negative cash flow from operations.
In the past 5 years CLSK always reported negative net income.
CLSK had negative operating cash flow in 4 of the past 5 years.
CLSK Yearly Net Income VS EBIT VS OCF VS FCFCLSK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100M -200M -300M

1.2 Ratios

CLSK's Return On Assets of 9.43% is amongst the best of the industry. CLSK outperforms 85.11% of its industry peers.
CLSK's Return On Equity of 13.62% is amongst the best of the industry. CLSK outperforms 80.50% of its industry peers.
Industry RankSector Rank
ROA 9.43%
ROE 13.62%
ROIC N/A
ROA(3y)-12.83%
ROA(5y)-29.98%
ROE(3y)-14.38%
ROE(5y)-38.48%
ROIC(3y)N/A
ROIC(5y)N/A
CLSK Yearly ROA, ROE, ROICCLSK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -100 -200 -300 -400

1.3 Margins

CLSK has a better Profit Margin (46.28%) than 94.68% of its industry peers.
The Gross Margin of CLSK (52.05%) is worse than 66.67% of its industry peers.
In the last couple of years the Gross Margin of CLSK has grown nicely.
Industry RankSector Rank
OM N/A
PM (TTM) 46.28%
GM 52.05%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.33%
GM growth 5Y29.35%
CLSK Yearly Profit, Operating, Gross MarginsCLSK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K

More info and screens

5

2. Health

2.1 Basic Checks

CLSK does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CLSK has been increased compared to 1 year ago.
The number of shares outstanding for CLSK has been increased compared to 5 years ago.
CLSK has a worse debt/assets ratio than last year.
CLSK Yearly Shares OutstandingCLSK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
CLSK Yearly Total Debt VS Total AssetsCLSK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

CLSK has an Altman-Z score of 2.09. This is not the best score and indicates that CLSK is in the grey zone with still only limited risk for bankruptcy at the moment.
CLSK has a Altman-Z score (2.09) which is comparable to the rest of the industry.
CLSK has a Debt/Equity ratio of 0.30. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of CLSK (0.30) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF N/A
Altman-Z 2.09
ROIC/WACCN/A
WACC11.21%
CLSK Yearly LT Debt VS Equity VS FCFCLSK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 4.37 indicates that CLSK has no problem at all paying its short term obligations.
CLSK has a better Current ratio (4.37) than 85.46% of its industry peers.
A Quick Ratio of 4.37 indicates that CLSK has no problem at all paying its short term obligations.
CLSK's Quick ratio of 4.37 is amongst the best of the industry. CLSK outperforms 85.46% of its industry peers.
Industry RankSector Rank
Current Ratio 4.37
Quick Ratio 4.37
CLSK Yearly Current Assets VS Current LiabilitesCLSK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 334.48% over the past year.
Looking at the last year, CLSK shows a very strong growth in Revenue. The Revenue has grown by 84.66%.
The Revenue has been growing by 142.70% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)334.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%485%
Revenue 1Y (TTM)84.66%
Revenue growth 3Y112.85%
Revenue growth 5Y142.7%
Sales Q2Q%90.81%

3.2 Future

The Earnings Per Share is expected to grow by 145.38% on average over the next years. This is a very strong growth
CLSK is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 48.64% yearly.
EPS Next Y1414.16%
EPS Next 2Y250.39%
EPS Next 3Y145.38%
EPS Next 5YN/A
Revenue Next Year96.22%
Revenue Next 2Y70.2%
Revenue Next 3Y48.64%
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
CLSK Yearly Revenue VS EstimatesCLSK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
CLSK Yearly EPS VS EstimatesCLSK Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -2 -4

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 14.04, which indicates a correct valuation of CLSK.
CLSK's Price/Earnings ratio is rather cheap when compared to the industry. CLSK is cheaper than 84.40% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.17. CLSK is valued slightly cheaper when compared to this.
CLSK is valuated reasonably with a Price/Forward Earnings ratio of 11.11.
88.65% of the companies in the same industry are more expensive than CLSK, based on the Price/Forward Earnings ratio.
CLSK's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.78.
Industry RankSector Rank
PE 14.04
Fwd PE 11.11
CLSK Price Earnings VS Forward Price EarningsCLSK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

82.27% of the companies in the same industry are more expensive than CLSK, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 18.49
CLSK Per share dataCLSK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6

4.3 Compensation for Growth

CLSK's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CLSK's earnings are expected to grow with 145.38% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.01
PEG (5Y)N/A
EPS Next 2Y250.39%
EPS Next 3Y145.38%

More info and screens

0

5. Dividend

5.1 Amount

CLSK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CLEANSPARK INC

NASDAQ:CLSK (8/28/2025, 8:01:14 PM)

After market: 9.59 +0.04 (+0.42%)

9.55

-0.03 (-0.31%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-07 2025-08-07/amc
Earnings (Next)12-01 2025-12-01/amc
Inst Owners62.76%
Inst Owner Change1.63%
Ins Owners2.28%
Ins Owner Change38.37%
Market Cap2.68B
Analysts83.33
Price Target22.23 (132.77%)
Short Float %22.01%
Short Ratio2.34
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.02
Dividend Growth(5Y)N/A
DP1.76%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-116.33%
Min EPS beat(2)-403.92%
Max EPS beat(2)171.26%
EPS beat(4)2
Avg EPS beat(4)-45.39%
Min EPS beat(4)-403.92%
Max EPS beat(4)171.26%
EPS beat(8)4
Avg EPS beat(8)44.86%
EPS beat(12)7
Avg EPS beat(12)30.55%
EPS beat(16)7
Avg EPS beat(16)-12.58%
Revenue beat(2)1
Avg Revenue beat(2)-3.44%
Min Revenue beat(2)-7.4%
Max Revenue beat(2)0.51%
Revenue beat(4)2
Avg Revenue beat(4)-0.86%
Min Revenue beat(4)-7.4%
Max Revenue beat(4)4.69%
Revenue beat(8)4
Avg Revenue beat(8)-0.74%
Revenue beat(12)5
Avg Revenue beat(12)-1.54%
Revenue beat(16)5
Avg Revenue beat(16)-4%
PT rev (1m)10.2%
PT rev (3m)11.36%
EPS NQ rev (1m)103.26%
EPS NQ rev (3m)31.94%
EPS NY rev (1m)49.77%
EPS NY rev (3m)-1.65%
Revenue NQ rev (1m)6.59%
Revenue NQ rev (3m)-9.79%
Revenue NY rev (1m)3.19%
Revenue NY rev (3m)0.09%
Valuation
Industry RankSector Rank
PE 14.04
Fwd PE 11.11
P/S 4.25
P/FCF N/A
P/OCF N/A
P/B 1.25
P/tB 1.33
EV/EBITDA 18.49
EPS(TTM)0.68
EY7.12%
EPS(NY)0.86
Fwd EY9%
FCF(TTM)-2.25
FCFYN/A
OCF(TTM)-1.51
OCFYN/A
SpS2.25
BVpS7.64
TBVpS7.15
PEG (NY)0.01
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 9.43%
ROE 13.62%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 46.28%
GM 52.05%
FCFM N/A
ROA(3y)-12.83%
ROA(5y)-29.98%
ROE(3y)-14.38%
ROE(5y)-38.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.33%
GM growth 5Y29.35%
F-Score2
Asset Turnover0.2
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF N/A
Debt/EBITDA 3.43
Cap/Depr 71.17%
Cap/Sales 32.87%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.37
Quick Ratio 4.37
Altman-Z 2.09
F-Score2
WACC11.21%
ROIC/WACCN/A
Cap/Depr(3y)65.93%
Cap/Depr(5y)337.91%
Cap/Sales(3y)31.8%
Cap/Sales(5y)89.99%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)334.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%485%
EPS Next Y1414.16%
EPS Next 2Y250.39%
EPS Next 3Y145.38%
EPS Next 5YN/A
Revenue 1Y (TTM)84.66%
Revenue growth 3Y112.85%
Revenue growth 5Y142.7%
Sales Q2Q%90.81%
Revenue Next Year96.22%
Revenue Next 2Y70.2%
Revenue Next 3Y48.64%
Revenue Next 5YN/A
EBIT growth 1Y-73.87%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year903.28%
EBIT Next 3Y119.15%
EBIT Next 5YN/A
FCF growth 1Y-60294%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1405.16%
OCF growth 3YN/A
OCF growth 5YN/A